Delivery Order SPE2DR25D3014-SPE2DR26FP2DF
Award Date 3/3/26
Potential Completion Date 3/4/26
Potential Value $1.4K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $2,761.54 delivery order to AmerisourceBergen Drug Corp on February 26, 2026, for ENGERIX-B 20 MCG/ML vaccine supply. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued at up to $999,999,999.00 through December 2026, which serves as a global pharmaceutical support vehicle enabling supply of pharmaceutical products and medical supplies to military healthcare programs worldwide. Place of performance is...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 5, 2026, for ENGERIX-B 20 MCG/ML vaccine with a ceiling value of $3,033.27. The order was placed against the parent IDC with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026 supporting military healthcare programs worldwide. Place of performance is Conshohocken, Pennsylvania. The delivery order uses firm fixed...
- The Defense Logistics Agency issued a $26,962.40 delivery order to Amerisourcebergen Drug Corp on February 4, 2026, for ENGERIX-B 20 MCG/ML vaccine supply, with completion by February 5, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which provides comprehensive global pharmaceutical support including vaccines, specialty medications, and medical supplies to military healthcare programs. Place of...
- The Defense Logistics Agency issued a $2,382.66 delivery order to AmerisourceBergen Drug Corp on February 26, 2026, for ENGERIX-B 20 MCG/ML vaccine supply. The order is issued under the parent Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026. This IDC serves as a global pharmaceutical support vehicle enabling supply of pharmaceutical products and medical supplies to support military healthcare programs worldwide,...
- The Defense Logistics Agency issued a $12,800.87 delivery order to Amerisourcebergen Drug Corp on March 2, 2026, for ENGERIX-B pediatric vaccine (10 mcg/0.5 mL syringe, 0.5 mL units). The order was placed under a parent Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026, which provides comprehensive pharmaceutical and medical supply support globally for military healthcare programs. Place of performance is Conshohocken, PA. The order...
- The Defense Logistics Agency issued a $1,074.40 delivery order to AmerisourceBergen Drug Corp on February 26, 2026, for ENGERIX-B 20 MCG/ML vaccine supply. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract valued at up to $999,999,999.00 and running through December 2026. AmerisourceBergen Drug Corp is a for-profit pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, where performance will occur. The order is firm fixed price with an ultimate...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 20, 2026, with a ceiling value of $22,437.48 for ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML vaccine supply. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026. This vehicle provides comprehensive global pharmaceutical support and medical supply delivery to military healthcare programs. Place of performance is...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 23, 2026, for ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML vaccine with a ceiling value of $17,259.60 under firm fixed-price terms. Place of performance is Conshohocken, PA. The order is issued under the parent DLA Troop Support Medical Indefinite Delivery Contract valued at $999,999,999.00 through December 2026, which covers pharmaceutical products and medical supplies to support military healthcare programs...
- <p>The Defense Logistics Agency issued a $1,466.74 delivery order to Amerisourcebergen Drug Corp on February 18, 2026, for ENGERIX-B 20 MCG/ML vaccine syringes.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of February 19, 2026. No set-aside was used.</p>
- <p>The Defense Logistics Agency issued a $1,031.25 delivery order to Amerisourcebergen Drug Corp on February 12, 2026, for ENGERIX-B 20 mcg/ml vaccine syringes, with ultimate completion on February 13, 2026.</p> <p>Place of performance is Conshohocken, PA. The order was issued under firm fixed-price pricing with no set-aside applied.</p>
- SPE2DR25D3014Indefinite Delivery Contract
- SPE2DR25D3014-SPE2DR26FP2DFDelivery Order
The Defense Logistics Agency issued a $1,375 delivery order to AmerisourceBergen Drug Corp on March 3, 2026, for ENGERIX-B 20 MCG/ML vaccine syringes. The order was placed under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999 through December 2026. Place of performance is Conshohocken, Pennsylvania. The order carries a firm fixed price structure with an ultimate completion date of March 4, 2026. No set-aside was used.
Generated 6/1/26, 10:43 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 3/2/26 |